Follow
Gail Skowron
Gail Skowron
Unknown affiliation
Verified email at brown.edu
Title
Cited by
Cited by
Year
Persistent and relapsing babesiosis in immunocompromised patients
PJ Krause, BE Gewurz, D Hill, FM Marty, E Vannier, IM Foppa, ...
Clinical Infectious Diseases 46 (3), 370-376, 2008
3492008
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384
GK Robbins, JG Spritzler, ES Chan, DM Asmuth, RT Gandhi, ...
Clinical Infectious Diseases 48 (3), 350-361, 2009
2952009
2′, 3′-didehydro-3′-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial
MJ Browne, KH Mayer, SBD Chafee, MN Dudley, MR Posner, ...
Journal of Infectious Diseases 167 (1), 21-29, 1993
2481993
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a phase I and II study
TC Merigan, G Skowron, SA Bozzette, D Richman, R Uttamchandani, ...
Annals of internal medicine 110 (3), 189-194, 1989
2461989
2', 3'‐Dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients
AR Berger, JC Arezzo, HH Schaumburg, G Skowron, T Merigan, ...
Neurology 43 (2), 358-358, 1993
2271993
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates
JM Whitcomb, W Huang, K Limoli, E Paxinos, T Wrin, G Skowron, ...
Aids 16 (15), F41-F47, 2002
1262002
Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach
AS De Groot, B Jesdale, W Martin, C Saint Aubin, H Sbai, A Bosma, ...
Vaccine 21 (27-30), 4486-4504, 2003
1182003
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus
DH Schwartz, G Skowron, TC Merigan
JAIDS Journal of Acquired Immune Deficiency Syndromes 4 (1), 11-23, 1991
981991
Causes of death in persons with human immunodeficiency virus infection
M Stein, P O'Sullivan, T Wachtel, A Fisher, D Mikolich, S Sepe, G Fort, ...
The American journal of medicine 93 (4), 387-390, 1992
941992
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex
G Skowron, SA Bozzette, L Lim, CB Pettinelli, HH Schaumburg, J Arezzo, ...
Annals of internal medicine 118 (5), 321-330, 1993
861993
Preventing transfusion‐transmitted babesiosis: preliminary experience of the first laboratory‐based blood donor screening program
C Young, A Chawla, V Berardi, J Padbury, G Skowron, PJ Krause, ...
Transfusion 52 (7), 1523-1529, 2012
802012
Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells
GK Sahu, K Sango, N Selliah, Q Ma, G Skowron, RP Junghans
Virology 446 (1-2), 268-275, 2013
752013
Biologic effects and safety of stavudine: overview of phase I and II clinical trials
G Skowron
Journal of Infectious Diseases 171 (Supplement_2), S113-S117, 1995
751995
the ddC Study Group of the AIDS Clinical Trials Group. 1989. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a …
TC Merigan, G Skowron, SA Bozzette, D Richman, R Uttamchandani, ...
Ann. Intern. Med 110, 189-194, 0
64
Reanalysis of Coreceptor Tropism in HIV-1–Infected Adults Using a Phenotypic Assay with Enhanced Sensitivity
TJ Wilkin, MB Goetz, R Leduc, G Skowron, Z Su, ES Chan, J Heera, ...
Clinical infectious diseases 52 (7), 925-928, 2011
602011
A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects
RC Kalayjian, G Skowron, RT Emgushov, M Chance, SA Spell, PR Borum, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 7 (4), 369-374, 1994
541994
Safety and tolerance of dideoxycytidine as a single agent: results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related …
TC Merigan, G Skowron
The American journal of medicine 88 (5), S11-S15, 1990
531990
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence
HIV Trialists' Collaborative Group
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 1999
501999
Baseline CD4+ cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy
G Skowron, JC Street, EM Obee
JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (4), 313-319, 2001
442001
Lack of pharmacokinetic interaction between nelfinavir and nevirapine
G Skowron, G Leoung, B Kerr, A Dusek, R Anderson, S Beebe, R Grosso
Aids 12 (10), 1243-1244, 1998
441998
The system can't perform the operation now. Try again later.
Articles 1–20